U. Liegl et al., INSULIN-DEPENDENT DIABETES-MELLITUS FOLLOWING PENTAMIDINE THERAPY IN A PATIENT WITH AIDS, The Clinical investigator, 72(12), 1994, pp. 1027-1029
Pentamidine is known to cause severe dysglycaemia by damaging beta-cel
l function of the pancreas. The exact mechanism still remains unclear.
We report the case of a 53-year-old man infected with the human immun
odeficiency virus who developed, insulin-dependent permanent diabetes
mellitus 3 days after starting intravenous treatment with pentamidine
for pneumocystis carinii pneumonia. Discharged from hospital the daily
need of insulin increased continuously over one year now requiring an
average dose of 80 units per day. So far, a number of cases of insuli
n-dependent diabetes mellitus following pentamidine therapy has been r
eported, but long-term observations are rare.